Hodgkin's Disease
Showing 1 - 25 of 92
Non-Hodgkin's Lymphoma and Hodgkin's Disease
Recruiting
- Lymphoma, Non-Hodgkin
- Hodgkin's Disease
-
Stanford, CaliforniaStanford University School of Medicine
Sep 9, 2022
Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T
Recruiting
- Hodgkin's Disease
- +3 more
- EBV-specific T cells: A
- EBV-specific T cells: B
-
Houston, Texas
- +1 more
Jun 28, 2022
Hodgkin's Disease Trial in Boston (Echo/Stress Echo)
Active, not recruiting
- Hodgkin's Disease
- Echo/Stress Echo
-
Boston, Massachusetts
- +1 more
Mar 28, 2022
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus
Active, not recruiting
- Acute Myelogenous Leukemia
- +10 more
- BL-8040
- +2 more
-
Atlanta, Georgia
- +2 more
Feb 9, 2022
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in
Completed
- Hodgkin's Disease
-
Louisville, KentuckyNorton Cancer Institute
Dec 14, 2021
Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)
Active, not recruiting
- Lymphoma
- +3 more
- TGFbeta resistant LMP-specific CTLs
-
Houston, Texas
- +1 more
Dec 8, 2021
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Winston-Salem
Recruiting
- Acute Myelogenous Leukemia
- +9 more
-
Winston-Salem, North CarolinaWake Forest Baptist Health
Nov 23, 2021
HIV, Hodgkin's Disease Trial in United States (Vinblastine sulfate, Dacarbazine, Filgrastim)
Completed
- HIV Infections
- Hodgkin's Disease
- Vinblastine sulfate
- +4 more
-
Birmingham, Alabama
- +7 more
Oct 26, 2021
CD20+, B-cell Lymphomas, Mantle Cell Lymphoma, Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) Trial in Baltimore
Completed
- CD20+, B-cell Lymphomas
- +5 more
- Everolimus
- Rituximab
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 4, 2021
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem
Terminated
- Leukemia, Myeloid, Acute
- +8 more
- Mesenchymal stem cells
- Isotonic solution
-
Edeghem, Antwerpen, Belgium
- +9 more
Aug 31, 2021
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Maywood, Durham
Completed
- Acute Lymphoblastic Leukemia (ALL)
- +4 more
-
Maywood, Illinois
- +1 more
Aug 1, 2021
Multiple Myeloma, Non-hodgkin's Lymphoma, Hodgkin's Disease Trial in Stony Brook (TG-0054)
Completed
- Multiple Myeloma
- +2 more
-
Stony Brook, New YorkStony Brook University Hospital
Apr 14, 2021
Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)
Terminated
- Leukemia, Myeloid, Chronic
- +8 more
- Stem Cell Transplant
- +5 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 31, 2020
Hodgkin's Disease, Non-Hodgkin's Lymphoma Trial in New York (Vorinostat, Niacinamide, Etoposide)
Completed
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
- Vorinostat
- +2 more
-
New York, New YorkCenter for Lymphoid Malignancies at CUMC
Nov 5, 2020
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
-
Tampa, Florida
- +11 more
Sep 3, 2020
Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated
Terminated
- Chronic Myelogenous Leukemia
- +7 more
- CD3/CD28 Activated T cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 12, 2020
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC
Completed
- Acute Myelogenous Leukemia
- +3 more
- Infusion of one MPC expanded cord unit and one unexpanded cord unit
- Infusion of two unexpanded cord blood units.
-
Miami, Florida
- +8 more
Jun 25, 2020
Non-Hodgkin's Lymphoma, Hodgkin's Disease Trial in Russian Federation, United States (SB-743921)
Completed
- Non-Hodgkin's Lymphoma
- Hodgkin's Disease
-
Hackensack, New Jersey
- +7 more
Jan 9, 2020
Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,
Completed
- Blood Cancer
- +7 more
- non-myeloablative hematopoietic cell transplantation
- +8 more
-
Stanford, CaliforniaStanford University School of Medicine
Nov 17, 2019
Hematological Malignancies, Leukemia, Lymphoma Trial in Philadelphia (Matched Sibling Allogeneic Transplantation)
Completed
- Hematological Malignancies
- +4 more
- Matched Sibling Allogeneic Transplantation
-
Philadelphia, PennsylvaniaThomas Jefferson University
Sep 27, 2019
Women Treated With Mediastinal Irradiation for Hodgkin's Disease
Completed
- Breast Cancer
- Hodgkin's Disease
- breast MRI
- Mammogram
-
Boston, Massachusetts
- +2 more
Apr 30, 2019
Lymphoma, Hodgkin's Disease Trial in Houston (Melphalan, Ara-C, VP-16)
Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/
Completed
- Acute Myeloid Leukemia
- +10 more
- fludarabine/busulfan
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago Medical Center
Oct 9, 2018
Hodgkin's Disease, Lymphoma Trial (Alemtuzumab (Campath-1H))
Withdrawn
- Hodgkin's Disease
- Lymphoma
- Alemtuzumab (Campath-1H)
- (no location specified)
Nov 6, 2018